AT107599B - Process for the preparation of durable, sterilizable solutions, which contain phosphorus in organic bonds as well as bound gold. - Google Patents

Process for the preparation of durable, sterilizable solutions, which contain phosphorus in organic bonds as well as bound gold.

Info

Publication number
AT107599B
AT107599B AT107599DA AT107599B AT 107599 B AT107599 B AT 107599B AT 107599D A AT107599D A AT 107599DA AT 107599 B AT107599 B AT 107599B
Authority
AT
Austria
Prior art keywords
solutions
durable
well
preparation
contain phosphorus
Prior art date
Application number
Other languages
German (de)
Original Assignee
Cassella Leopold & Co Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Leopold & Co Gmbh filed Critical Cassella Leopold & Co Gmbh
Application granted granted Critical
Publication of AT107599B publication Critical patent/AT107599B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

   <Desc/Clms Page number 1> 
 



  Verfahren zur Darstellung haltbarer, sterilisierbarer Lösungen, die Phosphor in organischer Bindung sowie gebundenes Gold enthalten. 



   Die im D. R. P. Nr. 397813 beschriebenen Salze der dialkylaminoarylphosphinigen Säure zersetzen sich beim Erhitzen ihrer wässerigen Lösungen unter Abspaltung der entsprechenden aromatischen Basen. 



   Es wurde nun die überraschende Beobachtung gemacht, dass man vollkommen haltbare und sterilisierbare Lösungen gewinnen kann, wenn man Lösungen der obenerwähnten   dialkylaminoaryl-   phosphinigsauren Salze und die in der Patentschrift Nr. 106213 beschriebenen Goldlösungen aufeinander einwirken lässt. Vermutlich handelt es sieh hiebei um die Bildung komplexer Anlagerungen. 



   Man erhält auf diese Weise Lösungen von hohem therapeutischem Wert, die ohne jede Reizwirkung eingespritzt werden können und die sowohl im Tierexperiment, als auch in ausgedehnten klinischen   Versuchen   keine schädlichen Nebenwirkungen-selbst bei Verwendung hoher Dosen-dagegen eine   vorzugliche Heilwirkung   bei der Behandlung tuberkulöser Prozesse gezeigt haben.

   
 EMI1.1 
 zuzuschreiben, denn klinische Versuche haben gezeigt, dass Phosphor in Form der dialkylaminoarylphosphinigen Säuren ein   wertvolles Unterstützungsmittel   bei der Heilung tuberkulöser Erkrankungen darstellt, und pharmakologisch sowohl wie klinisch wurden ausserdem die   analeptisehen   Eigenschaften dieser   Phosphor\ erbindungen nachgewiesen,   die namentlich bei der Goldbehandlung, die oft grosse Anforderungen an den Herzmuskel stellt, von Bedeutung sind. 



   Beispiel :   100 g Goldnatriumthiosulfat   und 25 g reines Natriumthiosulfat werden zusammen gelöst in   5l   Wasser ; man fügt eine Lösung von 50 g p-Dimethylaminotolylphosphinigsauren Natriums in 5   i !   Wasser hinzu und sterilisiert in der üblichen Weise in strömendem Wasserdampf ; die Lösung bleibt vollkommen klar. 



   Das   Mischungsverhältnis   der Komponenten kann in weiten Grenzen variiert werden. Auch kann man zur Erreichung des gewünschten Effektes entweder die Lösungen zusammenbringen und sterilisieren oder aber die festen Substanzen mischen, dann lösen und hierauf sterilisieren. 

**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.



   <Desc / Clms Page number 1>
 



  Process for the preparation of durable, sterilizable solutions, which contain phosphorus in organic bonds as well as bound gold.



   The salts of dialkylaminoarylphosphinous acid described in D.R.P. No. 397813 decompose when their aqueous solutions are heated, with the corresponding aromatic bases being split off.



   The surprising observation has now been made that completely durable and sterilizable solutions can be obtained if solutions of the above-mentioned dialkylaminoaryl phosphinous acid salts and the gold solutions described in patent specification No. 106213 are allowed to act on one another. Presumably it is a question of the formation of complex deposits.



   In this way, solutions of high therapeutic value are obtained, which can be injected without any irritation and which, in animal experiments as well as in extensive clinical trials, have shown no harmful side effects - even when using high doses - on the other hand, an excellent healing effect in the treatment of tubercular processes to have.

   
 EMI1.1
 This is because clinical trials have shown that phosphorus in the form of dialkylaminoarylphosphinic acids is a valuable aid in curing tuberculous diseases, and the analeptic properties of these phosphorus compounds have also been proven pharmacologically and clinically, especially in gold treatment, which is often great The demands placed on the heart muscle are important.



   Example: 100 g gold sodium thiosulphate and 25 g pure sodium thiosulphate are dissolved together in 5 l water; a solution of 50 g of sodium p-dimethylaminotolylphosphinous acid in 5 i! Add water and sterilize in the usual way in flowing steam; the solution remains perfectly clear.



   The mixing ratio of the components can be varied within wide limits. To achieve the desired effect, the solutions can either be brought together and sterilized, or the solid substances can be mixed, then dissolved and then sterilized.

** WARNING ** End of DESC field may overlap beginning of CLMS **.

 

Claims (1)

PATENT-ANSPRUCH : Verfahren zur Darstellung haltbarer, sterilisierbarer Lösungen, die Phosphor in organischer Bindung sowie gebundenes Gold enthalten, darin bestehend, dass man die nach dem Verfahren des Patentes Nr. 106243 hergestellten Lösungen auf Lösungen von dialkylaminoarylphosphinigsauren Salzen einwirken lässt, oder die festen Ausgangsmaterialien mischt und dann das Gemenge löst. **WARNUNG** Ende CLMS Feld Kannt Anfang DESC uberlappen**. PATENT CLAIM: Process for the preparation of durable, sterilizable solutions which contain phosphorus in organic bonds as well as bound gold, consisting in allowing the solutions prepared according to the process of patent no. 106243 to act on solutions of dialkylaminoarylphosphinous acid salts, or mixing the solid starting materials and then the Mixture dissolves. ** WARNING ** End of CLMS field may overlap beginning of DESC **.
AT107599D 1925-06-22 1926-05-31 Process for the preparation of durable, sterilizable solutions, which contain phosphorus in organic bonds as well as bound gold. AT107599B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE107599X 1925-06-22

Publications (1)

Publication Number Publication Date
AT107599B true AT107599B (en) 1927-10-25

Family

ID=29276185

Family Applications (1)

Application Number Title Priority Date Filing Date
AT107599D AT107599B (en) 1925-06-22 1926-05-31 Process for the preparation of durable, sterilizable solutions, which contain phosphorus in organic bonds as well as bound gold.

Country Status (1)

Country Link
AT (1) AT107599B (en)

Similar Documents

Publication Publication Date Title
AT107599B (en) Process for the preparation of durable, sterilizable solutions, which contain phosphorus in organic bonds as well as bound gold.
DE463805C (en) Process for the preparation of durable, sterilizable solutions which contain phosphorus in organic bonds and bound gold
AT126297B (en) Process for the production of preparations which increase the tone of the skin blood vessels.
DE1768575B2 (en)
CH122189A (en) Process for the production of a durable, sterilized solution that contains organically bound phosphorus and bound gold.
DE458837C (en) Process for the preparation of an aqueous solution of hexamethylenetetramine silver nitrate suitable for injections
AT142023B (en) Process for the manufacture of an agent for protecting the epidermis against infection and for healing skin diseases.
DE874061C (en) Process for the production of a blood-coagulant substance from the lungs
DE627813C (en) Process for the production of a disinfecting agent for protecting the skin against infections and for healing skin diseases
DE519531C (en) Process for the production of an easily water-soluble, colloidal silver-tannin-protein compound
DE346200C (en) Process for maintaining and increasing the medicinal properties of mineral mud
AT107595B (en) Process for the preparation of 2-amino-3-nitropyridine-5-sulfonic acid.
DE576445C (en) Process for the production of primula acid (primula saponin) from primula species
AT100211B (en) Process for the preparation of new organic arsenic compounds.
DE486830C (en) Process for the production of tanning products of oxidation from recent substances of vegetable origin
AT115379B (en) Process for the production of an agent for combating epidemics, especially for disinfecting stable rooms and the like. like
AT129490B (en) Process for obtaining the anterior pituitary lobe hormone, which is characterized by its development-promoting and stimulating effect on the gonads, in a pure state.
AT93837B (en) Process for liming hides and skins.
AT67783B (en) Process for the production of water-soluble silver-protein compounds.
OKAMURA ÜBER DIE BUFODESOXYCHOLSÄURE IN DER GALLE VON BUFO VULGARIS JAPONICA I. Mitteilung
AT84496B (en) Process for the production of strongly disinfecting soap.
AT152396B (en) Process for the preparation of durable therapeutic preparations from intestinal mucosa.
AT157535B (en) Process for the preparation of real aqueous or alcoholic solutions of sulfur, sulfur arsenic, sulfur antimony and sulfur selenium.
DE377367C (en) Disinfectants
DE334916C (en) Process for the representation of a raw petroleum equipment